scorecardresearch
Add as a preferred source on Google
Tuesday, November 11, 2025
TopicVaccine

Topic: Vaccine

Vaccine manufacturer Indian Immunologicals Ltd to launch dengue vaccine by January 2026

According to NCDC, there was a 333% surge in dengue cases from 2020 to 2021 and a 21% rise in number of cases between 2021 and 2022.

Blob that created history — tracking six-decade quest for respiratory syncytial virus vaccine

GlaxoSmithKline’s vaccine for respiratory syncytial virus was approved by The Medicines and Healthcare products Regulatory Agency in Britain on Monday.

Hope for chikungunya vaccine: French drugmaker reports 99% immune response in Phase 3 trial

Trial of live-attenuated vaccine VLA1553 was conducted in US, with high seroprotection rates observed in participants up to 180 days after vaccination. Study published in 'The Lancet'.

‘Very promising’: World’s first vaccine, tested in Vietnam, against African swine fever nears approval

After decades of failed attempts due to the complexity of the virus, two vaccines co-developed by US scientists being tested in large pilot schemes by Vietnamese companies, WHO said.

People lost faith in childhood vaccines during Covid pandemic, says UNICEF report

The data was a 'worrying warning signal' of rising vaccine hesitancy amid misinformation, dwindling trust in governments and political polarisation, UNICEF said.

Phase 2 trial of Moderna-Merck’s personalised cancer vaccine shows positive results

Treatment with Moderna’s experimental mRNA vaccine in combination with Merck’s immunotherapy technology reduced risk of cancer recurrence or death by 44%, the companies said.

Covid, low awareness, vaccine hesitancy — why Mumbai’s reeling from a measles outbreak

From 92% vaccination in 2019-20, the number of those given 1st dose dropped to 74% in 2021-22. This year, only 43% children in Mumbai had received 1st dose till October.

India vaccine against cervical cancer to be launched Thursday, ‘will combat global shortage’

The Serum Institute of India & Department of Biotechnology are set to launch the country's first indigenously developed Quadrivalent Human Papillomavirus vaccine against cervical cancer.

After Covid, mRNA vaccine for cancer? US researchers report initial success against melanoma

Mice treated with the mRNA vaccine, delivered like ones for Covid, showed reduction in tumours & long-term immune memory, says study by Tufts University researchers published in PNAS.

How ICAR grew 50 generations of virus over 1.5 years to develop lumpy skin disease vaccine

Lumpi-ProVac, a vaccine developed by 2 Indian Council of Agricultural Research institutes, was found effective in preventing lumpy skin disease in cattle & is ready for commercial launch.

On Camera

The govt’s ‘fix’ to speed up insolvency could add at least a year to the process

The proposed amendment to the Insolvency and Bankruptcy Code aims to reduce timelines and provide for a mechanism that involves minimal interaction with the court. It fails on both counts.

No more text-heavy ads, wider scope of services—ICAI’s ethics code overhaul to promote Indian CA firms

Open to public feedback until 26 November, the revised guidelines, among other changes, give CA firms more flexibility to advertise & promote their services.

‘Let them see’: Putin says new nuclear-powered missiles in the making, in message to Washington

At a ceremony felicitating Russian military engineers, Putin highlights Moscow’s 'parity' in defence technologies for the next century.

Bihar is where politics moves, and everything else stands still

Bihar is blessed with a land more fertile for revolutions than any in India. Why has it fallen so far behind then? Constant obsession with politics is at the root of its destruction.